G0F 2AB (500pmol/vial)1vial

(4R,5S)-4-METHYL-5-PHENYL-3-PROPIONYL-2-OXAZOLIDINONE, 97.0%, 1g

1-(Piperidin-4-ylmethyl)piperidin-4-ol dihydrochloride, 95%, 1g

(2s)-2-{[(benzyloxy)carbonyl]amino}-3-(3,4-dihydroxyphenyl)propanoic acid, 98%, 1g

2-[(4-methylbenzyl)amino]ethanol hydrochloride, 95.0%, 5g

Bis(4-isopropylphenyl)amine, 96%, 1g

3,3-Diethylthiacarbocyanine (iodide), 1g

5-Fluoro-2-methylbenzoic acid, 99.0%, 1g

(1S)-3,3'-Bis(4-nitrophenyl)[1,1'-binaphthalene]-2,2'-diol, ��97.0%, 100mg

Chelidonine, ROTICHROM® TLC, 25 mg, envase de vidrio

(S)-2-Amino-3-guanidinopropanoic acid dihydrochloride, 95.0%, 1g

Fmoc-L-Arg(Pbf)-OH, 96 %, 25g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-((3-methylpentan-3-yl)oxy)-4-oxobutanoic acid, 97%, 25g